Probiotics for recurrent Clostridium difficile disease

References

1. Bennett, R. G., Gorbach, S. L., Goldin, B., Chang, T.-W., Laughon, B. E., Greenough, W. B. & Bartlett, J. G. ( 1996;). Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutr Today 31, S35–S38.[CrossRef]
   [Google Scholar]
2. Dial, S., Alrasadi, K., Manoukian, C., Huang, A. & Menzies, D. ( 2004;). Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 171, 33–38.[CrossRef]
   [Google Scholar]
3. Gorbach, S. L., Chang, T.-W. & Goldin, B. ( 1987;). Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet ii, 1519. 1519.
   [Google Scholar]
4. Hopkins, M. J. & Macfarlane, G. T. ( 2002;). Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, 448–454.
   [Google Scholar]
5. McFarland, L. V. ( 2005;). Alternative treatments for Clostridium difficile disease: what really works? J Med Microbiol 54, 101–111.[CrossRef]
   [Google Scholar]
6. McFarland, L. V., Surawicz, C. M., Greenberg, R. N. & 10 other authors ( 1994;). A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271, 1913–1918.[CrossRef]
   [Google Scholar]
7. Pochapin, M. ( 2000;). The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 95, S11–S13.[CrossRef]
   [Google Scholar]
8. Surawicz, C. M., McFarland, L. V., Greenberg, R. N. & 8 other authors ( 2000;). The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31, 1012–1017.[CrossRef]
   [Google Scholar]
9. Wullt, M., Johansson Hagslätt, M.-L. & Odenholt, I. ( 2003;). Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 35, 365–367.[CrossRef]
   [Google Scholar]